Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Recombinant Human Growth Hormone (rhGH) Injection
DRUG
2 trials
Sponsors
Changchun GeneScience Pharmaceutical Co., Ltd.
, Anhui Provincial Hospital
Conditions
Acute Brain Injuries
Moderate to Severe Traumatic Brain Injury
Prader-Willi Syndrome
Phase 3
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome
NCT03554031
Changchun GeneScience Pharmaceutical Co., Ltd.
Prader-Willi Syndrome
Start: 2018-04-14
End: 2020-01-01
Target: 30
Updated: 2018-06-12
Phase 4
Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)
Not yet recruiting
NCT07481656
Anhui Provincial Hospital
Acute Brain Injuries, Moderate to Severe Traumatic Brain Injury
Start: 2026-04-10
End: 2028-10-30
Target: 160
Updated: 2026-03-19